{
    "nctId": "NCT01665300",
    "briefTitle": "Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity",
    "officialTitle": "Usefulness of Myocardial Deformation Imaging in Breast Cancer Patients Treated With Trastuzumab for Early Detection of Myocardial Dysfunction",
    "overallStatus": "COMPLETED",
    "conditions": "Left Ventricular Function Systolic Dysfunction, Cardiotoxicity",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "LV systolic dysfunction",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* HER2(+) breast cancer, anticipating Trastuzumab therapy\n\nExclusion Criteria:\n\n* Refusal to informed consent\n* Congenital heart disease\n* Significant arrhythmia in EKG\n* Regional wall motion abnormality (+) in echocardiography\n* Poor sonic window",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}